13F HOLDINGS REPORT
SR ONE CAPITAL MANAGEMENT, LP
Quarter ended Q3 2023 · Filed August 10, 2023 · Accession 0001910264-23-000005
Total Value
$231.9M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARCELLX INC | ACLX | 3,946,630 | $124.8M | 53.81% |
| 2 | DESIGN THERAPEUTICS INC | DSGN | 6,526,476 | $41.1M | 17.73% |
| 3 | MINERALYS THERAPEUTICS INC | MLYS | 1,794,600 | $30.6M | 13.19% |
| 4 | ARS PHARMACEUTICALS INC | SPRY | 4,012,903 | $26.9M | 11.59% |
| 5 | EFFECTOR THERAPEUTICS INC | 28202V108 | 6,822,114 | $5.6M | 2.41% |
| 6 | NKARTA INC | NKTX | 1,333,333 | $2.9M | 1.26% |